MYLAN 711
Pill imprint MYLAN 711 has been identified as Hydrochlorothiazide and methyldopa 25 mg / 250 mg.
Hydrochlorothiazide/methyldopa is used in the treatment of high blood pressure and belongs to the drug class antihypertensive combinations. Risk cannot be ruled out during pregnancy.
Hydrochlorothiazide/methyldopa 25 mg / 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Hydrochlorothiazide and methyldopa Images
- Imprint:
-
MYLAN
711 - Strength:
- 25 mg / 250 mg
- Color:
- Green
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0711
| NDC Code | Manufacturer / Repackager |
|---|---|
| 49999-0082 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
More Hydrochlorothiazide and Methyldopa resources
- Methyldopa/Hydrochlorothiazide (Wolters Kluwer)
- hydrochlorothiazide and methyldopa (Cerner Multum)
- methyldopa and hydrochlorothiazide (Micromedex) - Includes Dosage Information
- Methyldopa and Hydrochlorothiazide (FDA)


